|
GENE
|
Genetic Technologies Ltd
|
US
|
NASDAQ
|
|
GH
|
Guardant Health, Inc.
|
US
|
NASDAQ
|
|
GLMD
|
Galmed Pharmaceuticals Ltd.
|
US
|
NASDAQ
|
|
GLTO
|
Galecto, Inc.
|
US
|
NASDAQ
|
|
GMAB
|
Genmab A/S
|
US
|
NASDAQ
|
|
GMDA
|
Gamida Cell Ltd.
|
US
|
NASDAQ
|
|
GNPX
|
Genprex, Inc.
|
US
|
NASDAQ
|
|
GNTA
|
Genenta Science S.p.A.
|
US
|
NASDAQ
|
|
GOVX
|
GeoVax Labs, Inc.
|
US
|
NASDAQ
|
|
GRTS
|
Gritstone Oncology, Inc.
|
US
|
NASDAQ
|
|
GRTX
|
Galera Therapeutics, Inc.
|
US
|
NASDAQ
|
|
GSK
|
GlaxoSmithKline PLC
|
US
|
NYSE
|
|
GTBP
|
GT Biopharma, Inc.
|
US
|
NASDAQ
|
|
GTH
|
Genetron Holdings Limited
|
US
|
NASDAQ
|
|
GTHX
|
G1 Therapeutics, Inc.
|
US
|
NASDAQ
|
|
HARP
|
Harpoon Therapeutics, Inc.
|
US
|
NASDAQ
|
|
HGEN
|
Humanigen, Inc.
|
US
|
NASDAQ
|
|
HILS
|
Hillstream BioPharma, Inc.
|
US
|
NASDAQ
|
|
HOOK
|
HOOKIPA Pharma Inc.
|
US
|
NASDAQ
|
|
HOWL
|
Werewolf Therapeutics, Inc.
|
US
|
NASDAQ
|